HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hannes Deutschmann Selected Research
Hannes Deutschmann Research Topics
Disease
14
Stroke (Strokes)
12/2023 - 01/2013
6
Ischemic Stroke
11/2023 - 10/2013
4
Intracranial Hemorrhages (Intracranial Hemorrhage)
10/2023 - 01/2017
4
Pathologic Constriction (Stenosis)
01/2021 - 03/2004
2
Hemorrhage
01/2017 - 03/2004
2
Venous Thrombosis (Deep-Vein Thrombosis)
09/2012 - 04/2012
2
Thrombosis (Thrombus)
04/2012 - 03/2004
1
Epilepsy (Aura)
12/2023
1
Infarction (Infarctions)
11/2023
1
Inflammation (Inflammations)
11/2021
1
Acute Kidney Injury (Acute Renal Failure)
10/2021
1
Chronic Renal Insufficiency
10/2021
1
Chronic Pain
07/2021
1
Intractable Pain
07/2021
1
Atherosclerosis
01/2021
1
Insulin Resistance
01/2021
1
Liver Cirrhosis (Hepatic Cirrhosis)
01/2021
1
Mental Disorders (Mental Disorder)
01/2020
1
Bipolar Disorder (Manic Depressive Psychosis)
01/2020
1
Tremor (Tremors)
01/2019
1
Essential Tremor (Essential Tremors)
01/2019
1
Dystonia (Limb Dystonia)
01/2019
1
Brain Ischemia (Cerebral Ischemia)
11/2018
1
Body Weight (Weight, Body)
01/2017
1
Nephrogenic Fibrosing Dermopathy
01/2017
1
Coronary Artery Disease (Coronary Atherosclerosis)
10/2016
1
Peripheral Arterial Disease
09/2014
1
Peripheral Arterial Occlusive Disease 1
09/2014
1
Intracranial Aneurysm (Cerebral Aneurysm)
10/2013
1
Granuloma
10/2013
1
Aneurysm (Aneurysms)
06/2013
1
Fibromuscular Dysplasia
06/2013
1
Hyperplasia
02/2013
1
Embolic Stroke
01/2013
1
Pulmonary Embolism
04/2012
1
Ascites
03/2004
1
Retinal Artery Occlusion
07/2002
1
Hyperhomocysteinemia
07/2002
1
Retinal Vein Occlusion
06/2002
Drug/Important Bio-Agent (IBA)
2
Anticoagulants
IBA
01/2017 - 09/2012
2
Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)
IBA
07/2002 - 06/2002
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
11/2021
1
Antioxidants
IBA
11/2021
1
Analgesics (Analgesic Drugs)
IBA
07/2021
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
C-Reactive Protein
IBA
01/2021
1
Triglycerides (Triacylglycerol)
IBA
01/2021
1
LDL Lipoproteins (beta Lipoproteins)
IBA
01/2021
1
Cholesterol
IBA
01/2021
1
oxidized low density lipoprotein
IBA
01/2021
1
Antipsychotic Agents (Antipsychotics)
IBA
01/2020
1
antiarrhythmic peptide (AAP)
IBA
01/2020
1
Iron
IBA
01/2019
1
gadobutrol
IBA
01/2017
1
Vitamin K
FDA Link
01/2017
1
Fibrin
IBA
10/2013
1
cupric sulfide (CuS)
IBA
04/2012
1
Homocysteine
IBA
07/2002
Therapy/Procedure
11
Thrombectomy
12/2023 - 01/2018
5
Therapeutics
02/2023 - 01/2013
4
Stents
01/2021 - 03/2004
1
Transcranial Magnetic Stimulation
07/2021
1
Carotid Endarterectomy
01/2020
1
Endarterectomy (Thromboendarterectomy)
01/2018
1
Percutaneous Coronary Intervention
10/2016
1
Protective Devices (Safety Device)
10/2016
1
Punctures
09/2014
1
Vascular Closure Devices
09/2014
1
Endovascular Procedures
09/2014
1
Aftercare (After-Treatment)
06/2013
1
General Anesthesia
01/2013
1
Thrombolytic Therapy
04/2012
1
Transjugular Intrahepatic Portasystemic Shunt
03/2004